Gilead Sciences, Inc. (Nasdaq: GILD) today announced that Dietmar Berger, MD, PhD, will join the company on January 2, 2025, as Chief Medical Officer and will become a member of Gilead’s senior ...

Dec 12 (Reuters) - Gilead Sciences (GILD.O), opens new tab said on Thursday it has appointed Sanofi's Dietmar Berger as its chief medical officer, replacing incumbent Merdad Parsey, who is ...

This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free daily BioPharma Dive newsletter. Disputes like this aren’t rampant, Padlock’s ...

Gilead Sciences named former Sanofi executive Dietmar Berger as chief medical officer, effective Jan. 2, succeeding Merdad Parsey. Berger had held the same role at Sanofi, where he was also global ...

Roche alumnus Dietmar Berger has joined Sanofi as head of development ... with cell therapies from Kite/Gilead under a deal announced in 2016 – eventually led Berger to be tempted away to ...

Gilead appoints Sanofi official Dietmar Berger as next chief medical officer Price increases for five of the 10 drugs that contributed the most to a rise in U.S. medical spending in 2023 were not ...

December 12, 2024--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that Dietmar Berger, MD, PhD, will join the company on January 2, 2025, as Chief Medical Officer and will become a member of ...

Gilead Sciences has appointed Dietmar Berger as chief medical officer and a member of its senior leadership team. Berger, who will assume the role at the beginning of 2025, is a board-certified ...

(Reuters) -Gilead Sciences said on Thursday it has appointed Sanofi's Dietmar Berger as its chief medical officer, replacing incumbent Merdad Parsey, who is preparing to leave early next year. Berger, ...